human | Q5 |
P9984 | CANTIC ID | 981058523888706706 |
P2798 | Loop ID | 468758 |
P496 | ORCID iD | 0000-0002-5792-1164 |
P11686 | University of Barcelona authority ID | 981058523888706706 |
P1580 | University of Barcelona authority ID (former scheme) | a1389432 |
P214 | VIAF ID | 305870387 |
P69 | educated at | Complutense University of Madrid | Q219694 |
Severo Ochoa Molecular Biology Center | Q20013983 | ||
P108 | employer | University of Barcelona | Q219615 |
Scripps Research | Q793867 | ||
Institut d'Investigacions Biomèdiques August Pi i Sunyer | Q25422555 | ||
Severo Ochoa Molecular Biology Center | Q20013983 | ||
P734 | family name | Angulo | Q21504529 |
Angulo | Q21504529 | ||
Angulo | Q21504529 | ||
P735 | given name | Ana | Q482671 |
Ana | Q482671 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | female | Q6581072 |
Q35347846 | A temporal gate for viral enhancers to co-opt Toll-like-receptor transcriptional activation pathways upon acute infection |
Q34404551 | Ablation of the regulatory IE1 protein of murine cytomegalovirus alters in vivo pro-inflammatory TNF-alpha production during acute infection |
Q38095771 | Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction |
Q28550521 | An Interferon Regulated MicroRNA Provides Broad Cell-Intrinsic Antiviral Immunity through Multihit Host-Directed Targeting of the Sterol Pathway |
Q34755471 | An essential role of the enhancer for murine cytomegalovirus in vivo growth and pathogenesis |
Q57084132 | Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids |
Q36493007 | Cutting edge: Ly9 (CD229), a SLAM family receptor, negatively regulates the development of thymic innate memory-like CD8+ T and invariant NKT cells. |
Q27329902 | Cytomegalovirus m154 hinders CD48 cell-surface expression and promotes viral escape from host natural killer cell control |
Q30322144 | Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice |
Q33834411 | Dominance of virus over host factors in cross-species activation of human cytomegalovirus early gene expression |
Q33788669 | Elimination of ie1 significantly attenuates murine cytomegalovirus virulence but does not alter replicative capacity in cell culture |
Q33877530 | Enhancerless cytomegalovirus is capable of establishing a low-level maintenance infection in severely immunodeficient host tissues but fails in exponential growth. |
Q40335295 | Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. |
Q40207796 | Expression and function of NKG2D in CD4+ T cells specific for human cytomegalovirus. |
Q28477369 | Host defense against viral infection involves interferon mediated down-regulation of sterol biosynthesis |
Q39525113 | Human cytomegalovirus UL7, a homologue of the SLAM-family receptor CD229, impairs cytokine production |
Q33800239 | Identification of a boundary domain adjacent to the potent human cytomegalovirus enhancer that represses transcription of the divergent UL127 promoter |
Q39224323 | Immunoglobulin superfamily members encoded by viruses and their multiple roles in immune evasion. |
Q52537275 | Impaired immunoproteasome assembly and immune responses in PA28-/- mice. |
Q56169020 | Imprint of human cytomegalovirus infection on the NK cell receptor repertoire |
Q36934017 | In vivo competence of murine cytomegalovirus under the control of the human cytomegalovirus major immediate-early enhancer in the establishment of latency and reactivation |
Q28083186 | Infection homeostasis: implications for therapeutic and immune programming of metabolism in controlling infection |
Q27486065 | Inhibition of African swine fever virus binding and infectivity by purified recombinant virus attachment protein p12 |
Q57200903 | Inhibition of NKG2D expression in NK cells by cytokines secreted in response to human cytomegalovirus infection |
Q44130049 | Lymphotoxins and cytomegalovirus cooperatively induce interferon-beta, establishing host-virus détente. |
Q36756335 | Mapping and sequence of the gene encoding the African swine fever virion protein of M(r) 11500. |
Q40951265 | Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. |
Q36329073 | NK cell receptors involved in the response to human cytomegalovirus infection. |
Q57200894 | NKp46 and DNAM-1 NK-cell receptors drive the response to human cytomegalovirus-infected myeloid dendritic cells overcoming viral immune evasion strategies |
Q35678024 | Natural killer cell receptors for major histocompatibility complex class I and related molecules in cytomegalovirus infection. |
Q57200899 | Natural killer cell-mediated response to human cytomegalovirus-infected macrophages is modulated by their functional polarization |
Q36944091 | Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro |
Q36235786 | Novel Role of 3'UTR-Embedded Alu Elements as Facilitators of Processed Pseudogene Genesis and Host Gene Capture by Viral Genomes. |
Q37073608 | Phenotypes of major immediate-early gene mutants of mouse cytomegalovirus. |
Q33942045 | Principles of homeostasis in governing virus activation and latency. |
Q46028688 | Regulation of human cytomegalovirus by retinoic acid. |
Q38760564 | Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer |
Q41737446 | Regulation of transporter associated with antigen processing by phosphorylation. |
Q35840016 | Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells |
Q35382729 | Reversible inhibition of murine cytomegalovirus replication by gamma interferon (IFN-γ) in primary macrophages involves a primed type I IFN-signaling subnetwork for full establishment of an immediate-early antiviral state |
Q36281793 | Signaling Lymphocytic Activation Molecule Family Receptor Homologs in New World Monkey Cytomegaloviruses |
Q64078040 | Subversion of natural killer cell responses by a cytomegalovirus-encoded soluble CD48 decoy receptor |
Q42779866 | Temporal profiling of the coding and noncoding murine cytomegalovirus transcriptomes |
Q58198345 | The Magnitude of Interferon-γ Responses to Human Cytomegalovirus Is Predictive for HIV-1 Disease Progression |
Q39627859 | The activator protein 1 binding motifs within the human cytomegalovirus major immediate-early enhancer are functionally redundant and act in a cooperative manner with the NF-{kappa}B sites during acute infection |
Q37157169 | The mouse cytomegalovirus immediate-early 1 gene is not required for establishment of latency or for reactivation in the lungs |
Q36567141 | The transcription factor STAT-1 couples macrophage synthesis of 25-hydroxycholesterol to the interferon antiviral response |
Q40043683 | Transcriptional mapping of a late gene coding for the p12 attachment protein of African swine fever virus. |
Q91804889 | Viral CD229 (Ly9) homologs as new manipulators of host immunity |
Q35091211 | Viral enhancer mimicry of host innate-immune promoters |
Q37991604 | Viral immunomodulatory proteins: usurping host genes as a survival strategy. |
Q63345589 | Vitamin A Regulation of Viral Growth |
Search more.